Trial Profile
Clinical trial of phototherapy and vorinostat in the treatment of cutaneous T-cell lymphoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Vorinostat (Primary)
- Indications Cutaneous T-cell lymphoma
- Focus Adverse reactions
- 03 Dec 2015 New trial record